Competition Pharmaceutical manufacturing Pharmaceutical products 
European Pharmaceutical Review
DECEMBER 4, 2023
However, the knowledge generated using a PAT framework can help to seamlessly transfer these insights to pilot testing and manufacturing operations. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production. Enter the era of benchtop NMR solutions.
European Pharmaceutical Review
FEBRUARY 13, 2025
Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
JANUARY 24, 2025
Applying AI to GVDs Amassing comprehensive productand market-related data, GVDs demonstrate the value of a pharmaceutical product to various stakeholders, including payers, healthcare providers, and regulatory bodies. It leveraged experts input at key points in the process, to assess and validate the work.
European Pharmaceutical Review
SEPTEMBER 29, 2022
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.
Pharmaceutical Technology
FEBRUARY 15, 2023
In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.
Expert insights. Personalized for you.
105 
Let's personalize your content